MedTech investment in the time of Coronavirus
IW Capital recently invested into medtech innovator GPDQ. The raise has subsequently garnered significant press coverage, as opportunities to invest in MedTech businesses come to the fore. Despite a precautionary pause from private investors as a result of COVID-19, there are significant growth opportunities, even in the current climate, for businesses to prosper and grow. For those who have a structure in place to navigate the crisis and cater to the increased demand created in some sectors during lockdown, opportunity is rife.
The GPDQ raise was met with a warm response and was covered by a wide array of both business and medical publications. The coverage is testament to widening investor appetite to support businesses that have the potential to make an impact on society, alongside the opportunity for investment growth. Now is an opportune time to support and invest into SMEs looking to grow and scale, while recognising the new opportunities emerging in the MedTech and Bio-tech industries in particular as the demand for such services increases.
Forbes spoke to the CEO of GPDQ – Paul Roberts – about this very topic, and the shift that is being seen for on-demand doctor services, like those provided by GPDQ. Verdict medical devices and BDaily news both also spoke to Paul and IW Capital CEO Luke Davis, to explore the importance of private investors in growing businesses that can have an impact on national and global issues, such as Coronavirus. As investment providers, IW Capital have a duty to offer these opportunities to investors but also to make sure that innovative SMEs get the funding they require in order to grow.
The three articles mentioned above can be read in full below:
To find out more about IW Capital, or for more information on investment and non-executive opportunities, please speak to a member of the IW Capital team today on 020 7015 2250, or email email@example.com